Skip to main content
Fig. 5 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 5

From: Role of 18F-FDG PET/CT in evaluation of recently diagnosed breast cancer patients

Fig. 5

A 37-year-old female patient arrived with newly diagnosed left breast cancer (IDC grade II). a A PET MIP picture of the entire body indicated active left breast, axillary, hepatic, and osseous lesions. b, c, d, e Axial CECT and fused PET/CT images revealed large ill-defined mildly enhancing speculated metabolically active left breast retroareolar soft tissue mass focally infiltrating the overlying nipple with retraction, measuring about 29 × 39 × 59 mm and achieving up to 7.9 SUVmax with other adjacent small metabolically active parenchymal lesions at lower outer quadrant, in fused PET/CT images, measuring up to 10 × 15 mm and achieving up to 6.6 SUVmax, not appreciated in CT images alone. f, g Axial CECT and fused PET/CT images revealed few variable-sized left axillary lymph nodes, measuring up to 11 × 21 mm and achieving up to 6.3 SUVmax. h, i Axial CECT and fused PET/CT images revealed bilobar hypodense metabolically active hepatic focal lesions, the largest and most active of them is seen at subsegment IVa, measuring about 29 × 31 × 39 mm and achieving 15.2 SUVmax. j, k Axial CECT and fused PET/CT images revealed hypermetabolic lytic osseous lesion at LV3 body, achieving 12 SUVmax

Back to article page